NovaBridge Biosciences (NBP) Current Taxes (2019 - 2022)
NovaBridge Biosciences (NBP) posted quarterly Current Taxes of $9.1 million for Q4 2022, up 596.91% quarter-over-quarter from $1.3 million in Q2 2022.
Powered by 
Analysis
NovaBridge Biosciences (NBP) Current Taxes (2019 - 2022) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Current Taxes for 1 consecutive years, with $9.1 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Current Taxes changed N/A year-over-year to $9.1 million; the TTM figure through Dec 2022 stood at $9.1 million (changed N/A YoY), while the FY2022 annual figure was $9.4 million, changed N/A from the prior year.
- Current Taxes advanced to $9.1 million in Q4 2022 per NBP's latest filing, from $1.3 million in the prior quarter.
- Across five years, Current Taxes topped out at $9.1 million in Q4 2022 and bottomed at $1.3 million in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 76.32 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | NovaBridge Biosciences | 197.68 Mn | 197.68 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 9.11 Mn |
| Jun 30, 2022 | 1.31 Mn |
| Dec 31, 2019 | 9.68 Mn |